Quote:Previously Authorized Monoclonal Antibody Therapeutics critical to treating individuals and protecting some of our most vulnerable population... are NOT effective against currently circulating strains in the U.S.
The monoclonal antibodies he is talking about targeted the original spike protein of Covid-19. Of course leronlimab never targeted the spike protein but handled the inflammatory effects that were killing people. The modified spike protein in variants does not change leronlimab's effectiveness.
8